Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Clinics ; 69(2): 145-149, 2/2014. tab, graf
Article in English | LILACS | ID: lil-701377

ABSTRACT

OBJECTIVE: To evaluate the effect of blocking the angiotensin II AT-1 receptor by the systemic administration of candesartan on the expression of intercellular adhesion molecule-1 in the sclera and choroid of hypercholesterolemic rabbits. METHODS: New Zealand rabbits were divided into 3 groups, as follows: GI, which was fed a rabbit standard diet; GII, which was fed a hypercholesterolemic diet; and GIII, which received hypercholesterolemic diet plus candesartan. Samples of the rabbits' sclera and choroid were then studied by hematoxylin-eosin staining and histomorphometric and immunohistochemical analyses for intercellular adhesion molecule-1 expression. RESULTS: Histological analysis of hematoxylin- and eosin-stained sclera and choroid revealed that macrophages were rarely present in GI, and GII had significantly increased macrophage numbers compared to GIII. Moreover, in GII, the sclera and choroid morphometry showed a significant increase in thickness in comparison to GI and GIII. GIII presented a significant increase in thickness in relation to GI. Sclera and choroid immunohistochemical analysis for intercellular adhesion molecule-1 expression revealed a significant increase in immunoreactivity in GII in relation to GI and GIII. GIII showed a significant increase in immunoreactivity in relation to GI. CONCLUSION: Candesartan reduced the expression of intercellular adhesion molecule-1 and consequently macrophage accumulation in the sclera and choroid of hypercholesterolemic rabbits. .


Subject(s)
Animals , Male , Rabbits , Angiotensin II Type 1 Receptor Blockers/pharmacology , Benzimidazoles/pharmacology , Choroid/drug effects , Hypercholesterolemia/physiopathology , Intercellular Adhesion Molecule-1/drug effects , Sclera/drug effects , Tetrazoles/pharmacology , Choroid/anatomy & histology , Disease Models, Animal , Immunohistochemistry , Macrophages/drug effects , Macular Degeneration/physiopathology , Reference Values , Sclera/anatomy & histology
2.
Arq. bras. cardiol ; 78(2): 212-223, Feb. 2002. tab, graf
Article in Portuguese, English | LILACS | ID: lil-303906

ABSTRACT

OBJECTIVE: To assess the influence of the quality of sleep on the nocturnal physiological drop in blood pressure during ambulatory blood pressure monitoring. METHODS: We consecutively assessed ambulatory blood pressure monitoring, the degree of tolerance for the examination, and the quality of sleep in 168 patients with hypertension or with the suspected "white-coat" effect. Blood pressure fall during sleep associated with a specific questionnaire and an analogical visual scale of tolerance for ambulatory blood pressure monitoring were used to assess usual sleep and sleep on the day of examination. Two specialists in sleep disturbances classified the patients into 2 groups: those with normal sleep and those with abnormal sleep. RESULTS: Fifty-nine (35 percent) patients comprised the abnormal sleep group. Findings regarding the quality of sleep on the day of ambulatory blood pressure monitoring as compared with those regarding the quality of sleep on a usual day were different and were as follows, respectively: total duration of sleep (-12.4±4.7 versus -42.2±14.9 minutes, P=0.02), latency of sleep (0.4±2.7 versus 17±5.1 minutes, P<0.001), number of awakenings (0.1±0.1 versus 1.35±0.3 times, P<0.001), and tolerance for ambulatory blood pressure monitoring (8±0.2 versus 6.7±0.35, P=0.035). An abnormal drop in blood pressure during sleep occurred in 20 (18 percent) patients in the normal sleep group and in 14 (24 percent) patients in the abnormal sleep group, P=0.53. CONCLUSION: Ambulatory blood pressure monitoring causes sleep disturbances in some patients, and a positive association between quality of sleep and tolerance for the examination was observed


Subject(s)
Humans , Male , Female , Middle Aged , Blood Pressure , Blood Pressure Monitoring, Ambulatory , Sleep , Sleep Wake Disorders , Blood Pressure Monitoring, Ambulatory , Hypertension , Time Factors
3.
Arq. bras. cardiol ; 77(1): 77-84, July 2001. ilus, tab
Article in Portuguese, English | LILACS | ID: lil-288993

ABSTRACT

A 44-year-old woman had a transient ischemic stroke, fibroelastoma of the mitral valve being the source of the embolus. The patient evolved with neutropenia induced by ticlopidine after 10 days of treatment. We report the major clinical features, therapeutical options, and medicamentous toxicity resulting from the use of antiplatelet drugs


Subject(s)
Humans , Female , Adult , Fibroma/complications , Heart Neoplasms/complications , Ischemic Attack, Transient/etiology , Mitral Valve , Fibroma/diagnosis , Fibroma/therapy , Heart Neoplasms/diagnosis , Heart Neoplasms/therapy , Heart Valve Diseases/complications , Heart Valve Diseases/diagnosis , Heart Valve Diseases/therapy , Neutropenia/chemically induced , Platelet Aggregation Inhibitors/adverse effects , Ticlopidine/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL